OBJECTIVE: To investigate the application status of Chinese patent medicine by western clinicians in Beijing Shijitan Hospital

Capital Medical University（hereinafter referred to as “the hospital”）

so as to promote rational clinical drug application. METHODS: Through the information system of the hospital

all prescriptions issued by western clinicians in Sept. 2021 were collected

and the number and consumption sum of prescriptions of western medicine and Chinese patent medicine were statistically analyzed. Meanwhile

questionnaire survey was performed on the western clinicians who prescribe Chinese patent medicine

statistical analysis was carried out on the survey results. RESULTS: In Sept. 2021

the number of Chinese patent medicine prescriptions in the hospital was 22 778

among which 19 436 were issued by western clinicians（85.33%）. The consumption sum of Chinese patent medicine prescriptions was 7 242 432.68 yuan

among which the consumption sum of Chinese patent medicine prescriptions issued by western clinicians was 5 966 539.44 yuan（82.38%）. A total of 493 clinicians attending western medicine departments

of which 357 prescribed Chinese patent medicine（72.41%）. Results of the questionnaire survey showed that the application of Chinese patent medicine by western clinicians was more common

and most western clinicians had less understanding of the theory of traditional Chinese medicine. CONCLUSIONS: More than 80% of Chinese patent medicine prescriptions in general hospitals are issued by western clinicians

which poses medication risks. Relevant management departments can perform focused training and management by department and promote the rational clinical application of Chinese patent medicine through multiple channels and links.